NCT04361799View on ClinicalTrials.gov

Perioperative Closed-loop Glucose Control

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

September 2, 2021

Study Completion Date

September 2, 2021

Conditions
Perioperative HyperglycaemiaInsulin TherapyElective SurgeryClosed-Loop Glucose ControlArtificial Pancreas
Interventions
DEVICE

CamAPS

Fully automated closed-loop subcutaneous insulin delivery system. A model predictive controller modulates insulin delivery every 10-12 minutes based on interstitial glucose measurements.

DRUG

Standard insulin therapy

Standard insulin therapy according to local clinical practice.

Trial Locations (1)

3010

Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04361799 - Perioperative Closed-loop Glucose Control | Biotech Hunter | Biotech Hunter